Is there good empiric data to support the idea that narrow spectrum beta lactam plus aminoglycoside (as empiric therapy) is better than broad spectrum beta lactam, from stewardship point of view? What proportion of CPEs also carry aminoglycoside resistance genes? @idiots-pod.bsky.social